First Time Loading...

NU Skin Enterprises Inc
NYSE:NUS

Watchlist Manager
NU Skin Enterprises Inc Logo
NU Skin Enterprises Inc
NYSE:NUS
Watchlist
Price: 12.7 USD 2.75% Market Closed
Updated: Apr 19, 2024

Intrinsic Value

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of personal care products and nutritional supplements. [ Read More ]

The intrinsic value of one NUS stock under the Base Case scenario is 25.77 USD. Compared to the current market price of 12.7 USD, NU Skin Enterprises Inc is Undervalued by 51%.

Key Points:
NUS Intrinsic Value
Base Case
25.77 USD
Undervaluation 51%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
NU Skin Enterprises Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling NUS stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
NU Skin Enterprises Inc

Provide an overview of the primary business activities
of NU Skin Enterprises Inc.

What unique competitive advantages
does NU Skin Enterprises Inc hold over its rivals?

What risks and challenges
does NU Skin Enterprises Inc face in the near future?

Has there been any significant insider trading activity
in NU Skin Enterprises Inc recently?

Summarize the latest earnings call
of NU Skin Enterprises Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for NU Skin Enterprises Inc.

Provide P/S
for NU Skin Enterprises Inc.

Provide P/E
for NU Skin Enterprises Inc.

Provide P/OCF
for NU Skin Enterprises Inc.

Provide P/FCFE
for NU Skin Enterprises Inc.

Provide P/B
for NU Skin Enterprises Inc.

Provide EV/S
for NU Skin Enterprises Inc.

Provide EV/GP
for NU Skin Enterprises Inc.

Provide EV/EBITDA
for NU Skin Enterprises Inc.

Provide EV/EBIT
for NU Skin Enterprises Inc.

Provide EV/OCF
for NU Skin Enterprises Inc.

Provide EV/FCFF
for NU Skin Enterprises Inc.

Provide EV/IC
for NU Skin Enterprises Inc.

Show me price targets
for NU Skin Enterprises Inc made by professional analysts.

What are the Revenue projections
for NU Skin Enterprises Inc?

How accurate were the past Revenue estimates
for NU Skin Enterprises Inc?

What are the Net Income projections
for NU Skin Enterprises Inc?

How accurate were the past Net Income estimates
for NU Skin Enterprises Inc?

What are the EPS projections
for NU Skin Enterprises Inc?

How accurate were the past EPS estimates
for NU Skin Enterprises Inc?

What are the EBIT projections
for NU Skin Enterprises Inc?

How accurate were the past EBIT estimates
for NU Skin Enterprises Inc?

Compare the revenue forecasts
for NU Skin Enterprises Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of NU Skin Enterprises Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of NU Skin Enterprises Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of NU Skin Enterprises Inc compared to its peers.

Compare the P/E ratios
of NU Skin Enterprises Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing NU Skin Enterprises Inc with its peers.

Analyze the financial leverage
of NU Skin Enterprises Inc compared to its main competitors.

Show all profitability ratios
for NU Skin Enterprises Inc.

Provide ROE
for NU Skin Enterprises Inc.

Provide ROA
for NU Skin Enterprises Inc.

Provide ROIC
for NU Skin Enterprises Inc.

Provide ROCE
for NU Skin Enterprises Inc.

Provide Gross Margin
for NU Skin Enterprises Inc.

Provide Operating Margin
for NU Skin Enterprises Inc.

Provide Net Margin
for NU Skin Enterprises Inc.

Provide FCF Margin
for NU Skin Enterprises Inc.

Show all solvency ratios
for NU Skin Enterprises Inc.

Provide D/E Ratio
for NU Skin Enterprises Inc.

Provide D/A Ratio
for NU Skin Enterprises Inc.

Provide Interest Coverage Ratio
for NU Skin Enterprises Inc.

Provide Altman Z-Score Ratio
for NU Skin Enterprises Inc.

Provide Quick Ratio
for NU Skin Enterprises Inc.

Provide Current Ratio
for NU Skin Enterprises Inc.

Provide Cash Ratio
for NU Skin Enterprises Inc.

What is the historical Revenue growth
over the last 5 years for NU Skin Enterprises Inc?

What is the historical Net Income growth
over the last 5 years for NU Skin Enterprises Inc?

What is the current Free Cash Flow
of NU Skin Enterprises Inc?

Financials

Balance Sheet Decomposition
NU Skin Enterprises Inc

Current Assets 701.9m
Cash & Short-Term Investments 267.8m
Receivables 72.9m
Other Current Assets 361.2m
Non-Current Assets 1.1B
PP&E 523.1m
Intangibles 336.1m
Other Non-Current Assets 245.4m
Current Liabilities 328.9m
Accounts Payable 43.5m
Accrued Liabilities 260.4m
Other Current Liabilities 25m
Non-Current Liabilities 655.6m
Long-Term Debt 478m
Other Non-Current Liabilities 177.6m
Efficiency

Earnings Waterfall
NU Skin Enterprises Inc

Revenue
2B USD
Cost of Revenue
-611.9m USD
Gross Profit
1.4B USD
Operating Expenses
-1.3B USD
Operating Income
68.1m USD
Other Expenses
-59.5m USD
Net Income
8.6m USD

Free Cash Flow Analysis
NU Skin Enterprises Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

NUS Profitability Score
Profitability Due Diligence

NU Skin Enterprises Inc's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROE
Positive Free Cash Flow
Positive 3-Year Average ROIC
48/100
Profitability
Score

NU Skin Enterprises Inc's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

NUS Solvency Score
Solvency Due Diligence

NU Skin Enterprises Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Short-Term Solvency
Long-Term Solvency
50/100
Solvency
Score

NU Skin Enterprises Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NUS Price Targets Summary
NU Skin Enterprises Inc

Wall Street analysts forecast NUS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NUS is 15.81 USD with a low forecast of 14.14 USD and a high forecast of 17.85 USD.

Lowest
Price Target
14.14 USD
11% Upside
Average
Price Target
15.81 USD
24% Upside
Highest
Price Target
17.85 USD
41% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

NUS Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

NUS Price
NU Skin Enterprises Inc

1M 1M
+1%
6M 6M
-36%
1Y 1Y
-69%
3Y 3Y
-74%
5Y 5Y
-69%
10Y 10Y
-80%
Annual Price Range
12.7
52w Low
12.01
52w High
40.91
Price Metrics
Average Annual Return 2.29%
Standard Deviation of Annual Returns 27.45%
Max Drawdown -80%
Shares Statistics
Market Capitalization 628.7m USD
Shares Outstanding 49 664 400
Percentage of Shares Shorted 5.32%

NUS Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

NU Skin Enterprises Inc Logo
NU Skin Enterprises Inc

Country

United States of America

Industry

Consumer products

Market Cap

628.7m USD

Dividend Yield

1.9%

Description

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of personal care products and nutritional supplements. The company is headquartered in Provo, Utah and currently employs 4,600 full-time employees. Nu Skin develops and distributes beauty and wellness products that are sold worldwide under the Nu Skin, Pharmanex and ageLOC brands. Nu Skin offers beauty and personal care products that include Body, DR. Dana, Epoch, Nu Colour, Nutricentials, Tri-Phasic White and Tru Face. Pharmanex offers nutritional products, including ageLOC R2, ageLOC Vitality, ageLOC Youth, g3, LifePak, TR90 and S3 Scanner. The firm operates through seven segments, which consists of seven geographic Nu Skin segments, including Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, which includes Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, which also includes Macau, and Europe, Middle East and Africa, which includes Europe as well as Israel, Russia and South Africa.

Contact

UTAH
Provo
75 W Center St
+18013451000.0
https://www.nuskin.com/

IPO

1996-11-22

Employees

4 600

Officers

Executive Chairman of the Board
Mr. Steven J. Lund
President, CEO & Director
Mr. Ryan S. Napierski
Executive VP & Chief Scientific Officer
Dr. Joseph Y. Chang Ph.D.
Executive VP & General Counsel
Mr. Chayce David Clark
Strategic Advisor
Ms. Mang Yee Tang
Founder
Ms. Sandra N. Tillotson
Show More
Executive VP, Chief Accounting Officer & CFO
Mr. James D. Thomas
Senior VP & CTO
Mr. Joe Sueper
Chief Information Officer
Mr. Mark L. Adams
Show Less

See Also

Discover More
What is the Intrinsic Value of one NUS stock?

The intrinsic value of one NUS stock under the Base Case scenario is 25.77 USD.

Is NUS stock undervalued or overvalued?

Compared to the current market price of 12.7 USD, NU Skin Enterprises Inc is Undervalued by 51%.